title: What are the management issues for hepatitis C in dialysis patients?: natural history of hepatitis C in dialysis populations.
authors.affiliation: Department of Medicine, Division of Hepatology, University of Miami Miller School of Medicine, Miami, Florida.
authors.forename: Andres F
authors.initials: AF
authors.lastname: Carrion
authors.forename: Paul
authors.initials: P
authors.lastname: Martin
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D058070:Asymptomatic Diseases; D006528:Carcinoma, Hepatocellular / Q000150:complications; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy*; D006575:Heterocyclic Compounds, 3-Ring / Q000627:therapeutic use; D006801:Humans; D016030:Kidney Transplantation; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000150:complications; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000628:therapy; D000069616:Simeprevir; D000069474:Sofosbuvir; D013449:Sulfonamides / Q000627:therapeutic use; D014542:Uridine Monophosphate / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D006575:Heterocyclic Compounds, 3-Ring; D013449:Sulfonamides; D000069616:Simeprevir; D014542:Uridine Monophosphate; D000069474:Sofosbuvir